Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference
Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined an...
Saved in:
Published in | Clinical chemistry and laboratory medicine Vol. 55; no. 12; pp. 1849 - 1856 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
De Gruyter
26.10.2017
Walter De Gruyter & Company |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be “fit for purpose” and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups. |
---|---|
AbstractList | Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be “fit for purpose” and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups. Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be "fit for purpose" and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups.Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some uncertainty. What quality is needed and what measurement errors can be tolerated without jeopardizing patient safety should therefore be defined and specified for each analyte having clinical use. When these specifications are defined, the total examination process will be "fit for purpose" and the laboratory professionals should then set up rules to control the measuring systems to ensure they perform within specifications. The laboratory community has used different models to set performance specifications (PS). Recently, it was felt that there was a need to revisit different models and, at the same time, to emphasize the presuppositions for using the different models. Therefore, in 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) organized a Strategic Conference in Milan. It was felt that there was a need for more detailed discussions on, for instance, PS for EQAS, which measurands should use which models to set PS and how to set PS for the extra-analytical phases. There was also a need to critically evaluate the quality of data on biological variation studies and further discussing the use of the total error (TE) concept. Consequently, EFLM established five Task Finish Groups (TFGs) to address each of these topics. The TFGs are finishing their activity on 2017 and the content of this paper includes deliverables from these groups. |
Author | Ceriotti, Ferruccio Panteghini, Mauro Plebani, Mario Jones, Graham Sandberg, Sverre Oosterhuis, Wytze |
AuthorAffiliation | . |
AuthorAffiliation_xml | – name: . |
Author_xml | – sequence: 1 givenname: Mauro surname: Panteghini fullname: Panteghini, Mauro email: mauro.panteghini@unimi.it organization: Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy, Phone: +39 02 3904 2806, Fax: +39 02 50319835 – sequence: 2 givenname: Ferruccio surname: Ceriotti fullname: Ceriotti, Ferruccio organization: Central Laboratory, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy – sequence: 3 givenname: Graham surname: Jones fullname: Jones, Graham organization: SydPath, St Vincent’s Hospital, Sydney, NSW, Australia – sequence: 4 givenname: Wytze surname: Oosterhuis fullname: Oosterhuis, Wytze organization: Department of Clinical Chemistry and Haematology, Zuyderland Medical Center, Heerlen, The Netherlands – sequence: 5 givenname: Mario surname: Plebani fullname: Plebani, Mario organization: Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy – sequence: 6 givenname: Sverre surname: Sandberg fullname: Sandberg, Sverre organization: Norwegian Porphyria Centre, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29031018$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcuLFDEQh4OsuA-9epSAFy-9pjqvaQ_CMviCFQ_qOWSSypqlOxmTbmX-ezM7OyCLXpIcvq9SVb9zcpJyQkKeA7sECfK1c-PU9Qx0x7TuH5EzEFx3gnM4uXuLTqkeTsl5rbeMgZRCPyGn_cA4MFidkV9f52JnvIlY6ZypxxAT0i2WkMtkk0Nat-hiiM7OMadKY6Kj3eQm5bKjE_romvGGcrpDWyrNiYaSJzr_QPo5jjbR4w-OrnMKWLBVfUoeBztWfHZ_X5Dv7999W3_srr98-LS-uu6cUGruwgCbsOIWmB9A98xxYZUGrnjPRAgDb0ebPWj0lgUllPcbHrxfSSWt95ZfkFeHutuSfy5YZzPF6nBsfWFeqoFBggDRc9bQlw_Q27yU1LprlJJCDlqrRr24p5ZNG95sS5xs2ZnjRhsgDoArudaCwbg43-2urSGOBpjZB2f2wZl9cGYfXNMuH2jHyv8V3h6E33acsXi8KcuuPf7q-p-ilNDDSgz8D9AQr4s |
CitedBy_id | crossref_primary_10_1515_cclm_2023_0069 crossref_primary_10_1515_cclm_2023_0740 crossref_primary_10_17116_labs2022110315 crossref_primary_10_1515_cclm_2018_0603 crossref_primary_10_1515_cclm_2023_0027 crossref_primary_10_1515_cclm_2023_1314 crossref_primary_10_1016_j_jtemb_2019_126414 crossref_primary_10_1515_cclm_2021_0170 crossref_primary_10_1515_cclm_2023_1439 crossref_primary_10_1515_cclm_2019_0253 crossref_primary_10_1515_cclm_2024_0787 crossref_primary_10_1016_j_jmsacl_2023_01_002 crossref_primary_10_1515_cclm_2018_0098 crossref_primary_10_1515_cclm_2019_1336 crossref_primary_10_1515_almed_2022_0036 crossref_primary_10_1515_cclm_2020_0371 crossref_primary_10_1515_cclm_2022_0605 crossref_primary_10_1515_cclm_2022_0128 crossref_primary_10_1016_j_cca_2020_10_010 crossref_primary_10_1016_j_cca_2021_08_013 crossref_primary_10_1373_clinchem_2018_300954 crossref_primary_10_1515_cclm_2020_0017 crossref_primary_10_1515_cclm_2022_1257 crossref_primary_10_1016_j_PLABM_2018_e00097 crossref_primary_10_1515_almed_2023_0057 crossref_primary_10_1515_cclm_2024_1203 crossref_primary_10_1515_cclm_2024_0551 crossref_primary_10_1515_cclm_2019_1128 crossref_primary_10_1080_10408363_2024_2434562 crossref_primary_10_1515_cclm_2018_0343 crossref_primary_10_1515_cclm_2022_0806 crossref_primary_10_1515_cclm_2023_0045 crossref_primary_10_1515_cclm_2023_1257 crossref_primary_10_1515_almed_2019_0016 crossref_primary_10_1515_cclm_2022_0755 crossref_primary_10_1515_almed_2021_0097 crossref_primary_10_1515_cclm_2023_0965 crossref_primary_10_1515_cclm_2022_0032 crossref_primary_10_1515_cclm_2024_0168 crossref_primary_10_1515_labmed_2023_0098 crossref_primary_10_1002_jcla_23581 crossref_primary_10_11613_BM_2018_020502 crossref_primary_10_1016_j_clinbiochem_2018_03_007 crossref_primary_10_1515_almed_2020_0008 crossref_primary_10_1016_j_clinbiochem_2018_02_018 crossref_primary_10_1515_cclm_2023_1286 crossref_primary_10_1016_j_clinbiochem_2021_05_003 crossref_primary_10_1016_j_jtha_2023_12_013 crossref_primary_10_1515_almed_2023_0155 crossref_primary_10_1016_j_plabm_2020_e00199 crossref_primary_10_1016_j_cca_2024_120107 crossref_primary_10_1016_j_cca_2020_06_021 crossref_primary_10_37871_jbres1369 crossref_primary_10_1177_00045632241311453 crossref_primary_10_1016_j_cca_2023_117233 crossref_primary_10_1016_j_cca_2021_11_001 crossref_primary_10_1515_cclm_2019_0658 crossref_primary_10_1515_cclm_2018_1212 crossref_primary_10_1093_clinchem_hvab178 |
Cites_doi | 10.1515/CCLM.2010.020 10.1373/clinchem.2011.165308 10.1016/j.cca.2015.08.007 10.3109/10408363.2016.1150252 10.1373/clinchem.2016.258962 10.1016/j.cca.2013.11.022 10.1373/clinchem.2016.265058 10.1016/j.clinbiochem.2017.02.002 10.1016/j.clinbiochem.2017.03.009 10.1373/clinchem.2011.162719 10.1373/clinchem.2017.275115 10.1373/clinchem.2016.269811 10.1080/00365519950185175 10.1016/j.atherosclerosis.2012.03.035 10.1515/cclm-2015-0897 10.1007/s00769-009-0630-8 10.1016/j.atherosclerosis.2013.12.016 10.1515/CCLM.2010.140 10.1515/cclm-2016-0220 10.1373/clinchem.2011.168641 10.1177/000456329102800313 10.1080/003655101300133630 10.1515/cclm.2011.791 10.1016/j.cca.2014.04.002 10.1515/cclm-2016-0035 |
ContentType | Journal Article |
Copyright | Copyright Walter De Gruyter & Company 2017 |
Copyright_xml | – notice: Copyright Walter De Gruyter & Company 2017 |
CorporateAuthor | Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) |
CorporateAuthor_xml | – name: Task Force on Performance Specifications in Laboratory Medicine of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1515/cclm-2017-0772 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Biotechnology Research Abstracts MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1437-4331 |
EndPage | 1856 |
ExternalDocumentID | 29031018 10_1515_cclm_2017_0772 10_1515_cclm_2017_077255121849 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~D 29B 354 36B 4.4 53G 5GY 5RE AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAONY AAOQK AAOWA AAPJK AAQCX AARRE AASQH AAWFC AAXCG ABAOT ABAQN ABDRH ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABRQL ABUVI ABWLS ABXMZ ABYBW ACDEB ACEFL ACGFS ACIWK ACMKP ACPMA ACPRK ACUND ACXLN ACYCL ACZBO ADDWE ADEQT ADGQD ADGYE ADOZN AECWL AEDGQ AEGVQ AEICA AEJTT AEKEB AENEX AEQDQ AERZL AEXIE AFBAA AFBDD AFBQV AFCXV AFGDO AFGNR AFQUK AFRAH AFYRI AGBEV AHOVO AHVWV AHXUK AIERV AIKXB AIWOI AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR AMAVY ASYPN AZMOX BAKPI BBCWN BCIFA BWHEM CGQUA CS3 DU5 EBS EJD EMOBN F5P FSTRU HZ~ IY9 KDIRW N9A O9- OBC OBS OEB OES OHH OVD P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM AAYXX CITATION ABVMU CGR CUY CVF DBYYV ECM EIF NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c466t-f91bf83a10d91720c34a671363204ff934ff017f7eda0f646ddb3fdd8565adda3 |
ISSN | 1434-6621 1437-4331 |
IngestDate | Fri Jul 11 11:09:36 EDT 2025 Sun Jun 29 16:39:03 EDT 2025 Wed Feb 19 02:42:13 EST 2025 Tue Jul 01 02:49:29 EDT 2025 Thu Apr 24 23:04:51 EDT 2025 Thu Jul 10 10:38:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | biological variation outcome performance specifications |
Language | English |
License | This content is free. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c466t-f91bf83a10d91720c34a671363204ff934ff017f7eda0f646ddb3fdd8565adda3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.degruyter.com/document/doi/10.1515/cclm-2017-0772/pdf |
PMID | 29031018 |
PQID | 1965459776 |
PQPubID | 105421 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1951414230 proquest_journals_1965459776 pubmed_primary_29031018 crossref_citationtrail_10_1515_cclm_2017_0772 crossref_primary_10_1515_cclm_2017_0772 walterdegruyter_journals_10_1515_cclm_2017_077255121849 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-10-26 |
PublicationDateYYYYMMDD | 2017-10-26 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-26 day: 26 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Clinical chemistry and laboratory medicine |
PublicationTitleAlternate | Clin Chem Lab Med |
PublicationYear | 2017 |
Publisher | De Gruyter Walter De Gruyter & Company |
Publisher_xml | – name: De Gruyter – name: Walter De Gruyter & Company |
References | (ref731) 2011; 57 (ref21) 2014; 432 (ref61) 2015; 53 (ref111) 2016; 53 (ref641) 2016; 53 (ref141) 2016; 62 (ref1021) 2017; 63 (ref31) 2015; 53 (ref591) 2015; 53 (ref151) 2017; 55 (ref541) 2012; 50 (ref1041) 2017; 55 (ref561) 2015; 53 (ref391) 2015; 53 (ref831) 1991; 28 (ref101) 2015; 53 (ref131) 2013; 51 (ref161) 2017; 55 (ref91) 2015; 53 (ref571) 1999; 59 (ref361) 2017; 50 (ref231) 2017; 55 (ref551) 2014; 432 (ref721) 2010; 48 (ref601) 2015; 53 (ref941) 2012; 222 (ref281) 2017 (ref711) 2014; 432 (ref1011) 2016; 54 (ref801) 2015; 450 (ref121) 2015; 53 (ref481) 2016; 54 (ref751) 2015; 53 (ref651) 2015; 53 (ref221) 2015; 53 (ref621) 2015; 53 (ref511) 2017; 55 (ref291) 2011; 57 (ref921) 2015; 53 (ref881) 2016; 54 (ref671) 2016; 62 (ref311) 2017; 55 (ref741) 2013; 51 (ref41) 1999; 59 (ref661) 2013; 51 (ref321) 2006; 44 (ref501) 2017; 63 (ref791) 2016; 54 (ref631) 2015; 53 (ref961) 2002; 39 (ref341) 2015; 53 (ref871) 2015; 53 (ref401) 2014; 233 (ref581) 2010; 15 (ref971) 2017; 63 (ref531) 2010; 48 (ref411) 2012; 222 (ref191) 2010; 48 (ref471) 2017; 55 (ref1001) 2017; 55 (ref211) 2013; 51 (ref981) 2001; 61 (ref781) 2011; 57 (ref771) 2017; 55 (ref241) 2017; 55 (ref451) 2001; 61 (ref331) 2014; 52 (ref841) 2017; 55 (ref71) 2015; 53 (ref861) 2014; 52 (ref271) 2015; 450 (ref251) 2011; 57 (ref381) 2016; 54 (ref1031) 2017; 63 (ref261) 2016; 54 (ref181) 2014; 432 (ref851) 2006; 44 (ref51) 2010; 15 (ref01) 2010; 48 (ref431) 2002; 39 (ref821) 2011; 57 (ref441) 2017; 63 (ref461) 2017; 50 (ref891) 2017; 50 (ref81) 2016; 54 (ref991) 2017; 50 (ref11) 2012; 50 (ref761) 2017; 55 (ref811) 2017 (ref931) 2014; 233 (ref301) 1991; 28 (ref351) 2016; 54 (ref911) 2016; 54 (ref611) 2016; 54 (ref491) 2017; 63 (ref681) 2017; 55 (ref201) 2011; 57 (ref691) 2017; 55 |
References_xml | – volume: 48 start-page: 7 year: 2010 ident: ref01 article-title: Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement publication-title: Clin Chem Lab Med doi: 10.1515/CCLM.2010.020 – volume: 57 start-page: 1334 year: 2011 ident: ref821 article-title: Gross overestimation of total allowable error based on biological variation publication-title: Clin Chem doi: 10.1373/clinchem.2011.165308 – volume: 450 start-page: 125 year: 2015 ident: ref801 article-title: The calibrator value assignment protocol of the Abbott enzymatic creatinine assay is inadequate for ensuring suitable quality of serum measurements publication-title: Clin Chim Acta doi: 10.1016/j.cca.2015.08.007 – volume: 51 start-page: 973 year: 2013 ident: ref661 article-title: Defining acceptable limits for the metrological traceability of specific measurands publication-title: Clin Chem Lab Med – volume: 55 start-page: S146 year: 2017 ident: ref471 article-title: Impact of measurement error of plasma glucose on clinical classification: a simulation analysis publication-title: Clin Chem Lab Med – volume: 39 start-page: 213 year: 2002 ident: ref961 article-title: Decision limit for troponin I and assay performance publication-title: Ann Clin Biochem – volume: 54 start-page: 223 year: 2016 ident: ref261 article-title: Useful measures and models for analytical quality management in medical laboratories publication-title: Clin Chem Lab Med – volume: 53 start-page: 313 year: 2016 ident: ref641 article-title: Generation of data on within-subject biological variation in laboratory medicine: an update publication-title: Crit Rev Clin Lab Sci doi: 10.3109/10408363.2016.1150252 – volume: 51 start-page: 1719 year: 2013 ident: ref741 article-title: Standardization and analytical goals for glycated hemoglobin measurement publication-title: Clin Chem Lab Med – volume: 52 start-page: 951 year: 2014 ident: ref861 article-title: Harmonization of quality indicators in laboratory medicine. A preliminary consensus publication-title: Clin Chem Lab Med – volume: 55 start-page: S1068 year: 2017 ident: ref311 article-title: Estimates of within-subject biological variation for total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and apolipoproteins A1, B based on review of published papers using a critical appraisal check list – Results from the EFLM TFG-BVD publication-title: Clin Chem Lab Med – volume: 62 start-page: 1255 year: 2016 ident: ref671 article-title: Analytical bias exceeding desirable quality goal in 4 out of 5 common immunoassays: results of a native single serum sample external quality assessment program for cobalamin, folate, ferritin, thyroid-stimulating hormone, and free T4 analyses publication-title: Clin Chem doi: 10.1373/clinchem.2016.258962 – volume: 432 start-page: 55 year: 2014 ident: ref551 article-title: Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies publication-title: Clin Chim Acta doi: 10.1016/j.cca.2013.11.022 – volume: 53 start-page: 841 year: 2015 ident: ref391 article-title: Setting analytical performance specifications based on outcome studies – is it possible? publication-title: Clin Chem Lab Med – volume: 63 start-page: 585 year: 2017 ident: ref441 article-title: Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision publication-title: Clin Chem doi: 10.1373/clinchem.2016.265058 – volume: 55 start-page: e47 year: 2017 ident: ref681 article-title: Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories publication-title: Clin Chem Lab Med – volume: 55 start-page: S170 year: 2017 ident: ref1041 article-title: Biological variation estimates obtained from 91 healthy subjects for six electrolytes in serum. EBIOVAR study of the EFLM Working-Group on Biological Variation publication-title: Clin Chem Lab Med – volume: 53 start-page: 905 year: 2015 ident: ref121 article-title: Performance criteria for combined uncertainty budget in the implementation of metrological traceability publication-title: Clin Chem Lab Med – volume: 50 start-page: 550 year: 2017 ident: ref361 article-title: Performance specifications for the extra-analytical phases of laboratory testing: Why and how publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2017.02.002 – volume: 50 start-page: 587 year: 2017 ident: ref461 article-title: Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2017.03.009 – volume: 57 start-page: 1204 year: 2011 ident: ref201 article-title: The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different publication-title: Clin Chem doi: 10.1373/clinchem.2011.162719 – volume: 53 start-page: 871 year: 2015 ident: ref621 article-title: Reliability of biological variation data available in an online database: need for improvement publication-title: Clin Chem Lab Med – volume: 53 start-page: 919 year: 2015 ident: ref221 article-title: Analytical performance specifications for EQA schemes – need for harmonisation publication-title: Clin Chem Lab Med – volume: 63 start-page: 1527 year: 2017 ident: ref501 article-title: The EuBIVAS Project: Within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring publication-title: Clin Chem doi: 10.1373/clinchem.2017.275115 – volume: 54 start-page: 523 year: 2016 ident: ref911 article-title: Laboratory medicine in the new healthcare environment publication-title: Clin Chem Lab Med – volume: 63 start-page: 1141 year: 2017 ident: ref1021 article-title: Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum publication-title: Clin Chem doi: 10.1373/clinchem.2016.269811 – volume: 59 start-page: 475 year: 1999 ident: ref571 article-title: The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25–26 April 1999 publication-title: Scand J Clin Lab Invest doi: 10.1080/00365519950185175 – volume: 63 start-page: 1141 year: 2017 ident: ref491 article-title: Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum publication-title: Clin Chem doi: 10.1373/clinchem.2016.269811 – volume: 53 start-page: 919 year: 2015 ident: ref751 article-title: Analytical performance specifications for EQA schemes – need for harmonisation publication-title: Clin Chem Lab Med – volume: 53 start-page: 829 year: 2015 ident: ref591 article-title: Defining analytical performance specifications 15 years after the Stockholm conference publication-title: Clin Chem Lab Med – volume: 222 start-page: 564 year: 2012 ident: ref941 article-title: A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2012.03.035 – volume: 44 start-page: 750 year: 2006 ident: ref321 article-title: Errors in clinical laboratories or errors in laboratory medicine? publication-title: Clin Chem Lab Med – volume: 53 start-page: 837 year: 2015 ident: ref31 article-title: The 1999 Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine publication-title: Clin Chem Lab Med – volume: 54 start-page: 1169 year: 2016 ident: ref881 article-title: Performance criteria and quality indicators for the post-analytical phase publication-title: Clin Chem Lab doi: 10.1515/cclm-2015-0897 – volume: 15 start-page: 323 year: 2010 ident: ref51 article-title: Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm Consensus Conference publication-title: Accred Qual Assur doi: 10.1007/s00769-009-0630-8 – volume: 233 start-page: 83 year: 2014 ident: ref931 article-title: Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2013.12.016 – volume: 55 start-page: S146 year: 2017 ident: ref1001 article-title: Impact of measurement error of plasma glucose on clinical classification: a simulation analysis publication-title: Clin Chem Lab Med – volume: 432 start-page: 55 year: 2014 ident: ref21 article-title: Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies publication-title: Clin Chim Acta doi: 10.1016/j.cca.2013.11.022 – volume: 48 start-page: 623 year: 2010 ident: ref191 article-title: Recommendations for the implementation of international standardization of glycated hemoglobin in Italy publication-title: Clin Chem Lab Med doi: 10.1515/CCLM.2010.140 – volume: 53 start-page: 879 year: 2015 ident: ref101 article-title: A checklist for critical appraisal of studies of biological variation publication-title: Clin Chem Lab Med – volume: 54 start-page: 223 year: 2016 ident: ref791 article-title: Useful measures and models for analytical quality management in medical laboratories publication-title: Clin Chem Lab Med – volume: 55 start-page: e47 year: 2017 ident: ref151 article-title: Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories publication-title: Clin Chem Lab Med – volume: 450 start-page: 125 year: 2015 ident: ref271 article-title: The calibrator value assignment protocol of the Abbott enzymatic creatinine assay is inadequate for ensuring suitable quality of serum measurements publication-title: Clin Chim Acta doi: 10.1016/j.cca.2015.08.007 – volume: 53 start-page: 837 year: 2015 ident: ref561 article-title: The 1999 Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine publication-title: Clin Chem Lab Med – volume: 55 start-page: 334 year: 2017 ident: ref771 article-title: Progress and impact of enzyme measurement standardization publication-title: Clin Chem Lab Med – volume: 63 start-page: 1527 year: 2017 ident: ref1031 article-title: The EuBIVAS Project: Within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring publication-title: Clin Chem doi: 10.1373/clinchem.2017.275115 – volume: 55 start-page: 203 year: 2017 ident: ref691 article-title: Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2016-0220 – volume: 52 start-page: 951 year: 2014 ident: ref331 article-title: Harmonization of quality indicators in laboratory medicine. A preliminary consensus publication-title: Clin Chem Lab Med – volume: 53 start-page: 829 year: 2015 ident: ref61 article-title: Defining analytical performance specifications 15 years after the Stockholm conference publication-title: Clin Chem Lab Med – volume: 48 start-page: 7 year: 2010 ident: ref531 article-title: Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement publication-title: Clin Chem Lab Med doi: 10.1515/CCLM.2010.020 – volume: 57 start-page: 1670 year: 2011 ident: ref251 article-title: Proficiency testing/external quality assessment: current challenges and future directions publication-title: Clin Chem doi: 10.1373/clinchem.2011.168641 – volume: 55 start-page: 949 year: 2017 ident: ref761 article-title: Analytical performance specifications for external quality assessment – definitions and descriptions publication-title: Clin Chem Lab Med – volume: 28 start-page: 272 year: 1991 ident: ref301 article-title: A comparison of analytical goals for haemoglobin A1c assays derived using different strategies publication-title: Ann Clin Biochem doi: 10.1177/000456329102800313 – volume: 50 start-page: 550 year: 2017 ident: ref891 article-title: Performance specifications for the extra-analytical phases of laboratory testing: Why and how publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2017.02.002 – volume: 54 start-page: 1169 year: 2016 ident: ref351 article-title: Performance criteria and quality indicators for the post-analytical phase publication-title: Clin Chem Lab doi: 10.1515/cclm-2015-0897 – volume: 61 start-page: 191 year: 2001 ident: ref451 article-title: Evaluation of systematic and random factors in measurements of FPG as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus publication-title: Scand J Clin Lab Invest doi: 10.1080/003655101300133630 – volume: 54 start-page: 523 year: 2016 ident: ref381 article-title: Laboratory medicine in the new healthcare environment publication-title: Clin Chem Lab Med – volume: 15 start-page: 323 year: 2010 ident: ref581 article-title: Strategies to set global analytical quality specifications in laboratory medicine: 10 years on from the Stockholm Consensus Conference publication-title: Accred Qual Assur doi: 10.1007/s00769-009-0630-8 – volume: 55 start-page: S1068 year: 2017 ident: ref841 article-title: Estimates of within-subject biological variation for total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and apolipoproteins A1, B based on review of published papers using a critical appraisal check list – Results from the EFLM TFG-BVD publication-title: Clin Chem Lab Med – volume: 53 start-page: 313 year: 2016 ident: ref111 article-title: Generation of data on within-subject biological variation in laboratory medicine: an update publication-title: Crit Rev Clin Lab Sci doi: 10.3109/10408363.2016.1150252 – volume: 57 start-page: 1670 year: 2011 ident: ref781 article-title: Proficiency testing/external quality assessment: current challenges and future directions publication-title: Clin Chem doi: 10.1373/clinchem.2011.168641 – volume: 59 start-page: 475 year: 1999 ident: ref41 article-title: The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25–26 April 1999 publication-title: Scand J Clin Lab Invest doi: 10.1080/00365519950185175 – year: 2017 ident: ref281 article-title: The use of error and uncertainty methods in the medical laboratory publication-title: Clin Chem Lab Med – volume: 57 start-page: 1334 year: 2011 ident: ref291 article-title: Gross overestimation of total allowable error based on biological variation publication-title: Clin Chem doi: 10.1373/clinchem.2011.165308 – volume: 28 start-page: 272 year: 1991 ident: ref831 article-title: A comparison of analytical goals for haemoglobin A1c assays derived using different strategies publication-title: Ann Clin Biochem doi: 10.1177/000456329102800313 – volume: 51 start-page: 1719 year: 2013 ident: ref211 article-title: Standardization and analytical goals for glycated hemoglobin measurement publication-title: Clin Chem Lab Med – volume: 233 start-page: 83 year: 2014 ident: ref401 article-title: Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2013.12.016 – year: 2017 ident: ref811 article-title: The use of error and uncertainty methods in the medical laboratory publication-title: Clin Chem Lab Med – volume: 51 start-page: 973 year: 2013 ident: ref131 article-title: Defining acceptable limits for the metrological traceability of specific measurands publication-title: Clin Chem Lab Med – volume: 44 start-page: 750 year: 2006 ident: ref851 article-title: Errors in clinical laboratories or errors in laboratory medicine? publication-title: Clin Chem Lab Med – volume: 55 start-page: 334 year: 2017 ident: ref241 article-title: Progress and impact of enzyme measurement standardization publication-title: Clin Chem Lab Med – volume: 50 start-page: 1237 year: 2012 ident: ref11 article-title: Implementation of standardization in clinical practice: not always an easy task publication-title: Clin Chem Lab Med doi: 10.1515/cclm.2011.791 – volume: 39 start-page: 213 year: 2002 ident: ref431 article-title: Decision limit for troponin I and assay performance publication-title: Ann Clin Biochem – volume: 53 start-page: 833 year: 2015 ident: ref601 article-title: Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine publication-title: Clin Chem Lab Med – volume: 53 start-page: 841 year: 2015 ident: ref921 article-title: Setting analytical performance specifications based on outcome studies – is it possible? publication-title: Clin Chem Lab Med – volume: 432 start-page: 127 year: 2014 ident: ref181 article-title: Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits publication-title: Clin Chim Acta doi: 10.1016/j.cca.2014.04.002 – volume: 48 start-page: 623 year: 2010 ident: ref721 article-title: Recommendations for the implementation of international standardization of glycated hemoglobin in Italy publication-title: Clin Chem Lab Med doi: 10.1515/CCLM.2010.140 – volume: 54 start-page: 195 year: 2016 ident: ref81 article-title: Total error vs. measurement uncertainty: the match continues publication-title: Clin Chem Lab Med – volume: 432 start-page: 127 year: 2014 ident: ref711 article-title: Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits publication-title: Clin Chim Acta doi: 10.1016/j.cca.2014.04.002 – volume: 55 start-page: 203 year: 2017 ident: ref161 article-title: Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2016-0220 – volume: 50 start-page: 587 year: 2017 ident: ref991 article-title: Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2017.03.009 – volume: 54 start-page: 195 year: 2016 ident: ref611 article-title: Total error vs. measurement uncertainty: the match continues publication-title: Clin Chem Lab Med – volume: 55 start-page: 949 year: 2017 ident: ref231 article-title: Analytical performance specifications for external quality assessment – definitions and descriptions publication-title: Clin Chem Lab Med – volume: 54 start-page: 1599 year: 2016 ident: ref1011 article-title: Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2016-0035 – volume: 55 start-page: S170 year: 2017 ident: ref511 article-title: Biological variation estimates obtained from 91 healthy subjects for six electrolytes in serum. EBIOVAR study of the EFLM Working-Group on Biological Variation publication-title: Clin Chem Lab Med – volume: 54 start-page: 1599 year: 2016 ident: ref481 article-title: Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2016-0035 – volume: 222 start-page: 564 year: 2012 ident: ref411 article-title: A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE publication-title: Atheroscler doi: 10.1016/j.atherosclerosis.2012.03.035 – volume: 53 start-page: 943 year: 2015 ident: ref871 article-title: Performance criteria and quality indicators for the pre-analytical phase publication-title: Clin Chem Lab Med – volume: 61 start-page: 191 year: 2001 ident: ref981 article-title: Evaluation of systematic and random factors in measurements of FPG as the basis for analytical quality specifications in the diagnosis of diabetes. 3. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus publication-title: Scand J Clin Lab Invest doi: 10.1080/003655101300133630 – volume: 53 start-page: 905 year: 2015 ident: ref651 article-title: Performance criteria for combined uncertainty budget in the implementation of metrological traceability publication-title: Clin Chem Lab Med – volume: 53 start-page: 943 year: 2015 ident: ref341 article-title: Performance criteria and quality indicators for the pre-analytical phase publication-title: Clin Chem Lab Med – volume: 53 start-page: 833 year: 2015 ident: ref71 article-title: Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine publication-title: Clin Chem Lab Med – volume: 53 start-page: 871 year: 2015 ident: ref91 article-title: Reliability of biological variation data available in an online database: need for improvement publication-title: Clin Chem Lab Med – volume: 63 start-page: 585 year: 2017 ident: ref971 article-title: Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to assay bias and imprecision publication-title: Clin Chem doi: 10.1373/clinchem.2016.265058 – volume: 50 start-page: 1237 year: 2012 ident: ref541 article-title: Implementation of standardization in clinical practice: not always an easy task publication-title: Clin Chem Lab Med doi: 10.1515/cclm.2011.791 – volume: 53 start-page: 879 year: 2015 ident: ref631 article-title: A checklist for critical appraisal of studies of biological variation publication-title: Clin Chem Lab Med – volume: 57 start-page: 1204 year: 2011 ident: ref731 article-title: The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different publication-title: Clin Chem doi: 10.1373/clinchem.2011.162719 – volume: 62 start-page: 1255 year: 2016 ident: ref141 article-title: Analytical bias exceeding desirable quality goal in 4 out of 5 common immunoassays: results of a native single serum sample external quality assessment program for cobalamin, folate, ferritin, thyroid-stimulating hormone, and free T4 analyses publication-title: Clin Chem doi: 10.1373/clinchem.2016.258962 |
SSID | ssj0015547 |
Score | 2.4353468 |
Snippet | Measurements in clinical laboratories produce results needed in the diagnosis and monitoring of patients. These results are always characterized by some... |
SourceID | proquest pubmed crossref walterdegruyter |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1849 |
SubjectTerms | biological variation Clinical Laboratory Techniques - standards Clinical Medicine - standards Humans Laboratories Laboratories - standards Medicine outcome performance specifications Quality Control Specifications |
Title | Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference |
URI | https://www.degruyter.com/doi/10.1515/cclm-2017-0772 https://www.ncbi.nlm.nih.gov/pubmed/29031018 https://www.proquest.com/docview/1965459776 https://www.proquest.com/docview/1951414230 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FVuJxqKC8AgUtEhKHysXOrl_cStRSIYVTC71Z3odppJBUwQalP4jfyYz3YacEqXBxorW9a-_3eXdmZ2eGkNdlyMooTnmguGYBZzoKMjligeBlKrKS81Tggv7kU3Jyxj-ex-eDwa_erqWmFgfyaqNfyf-gCmWAK3rJ_gOyvlIogP-ALxwBYTjeCGMXWtaEaVC6QpHxsucKgH6UuBeo2zFuQUfLujOr46IA218B5VvTgXc4mUxn-PHbNmTPObAv0Y6da6V0qeNae8SGdjprFYaouJi2yaT2J2WzXHhLCPTaojY7DI71Engnp_6kTytgvLv98jC6qSwvGhMs4cuqvtL9pQyYHmEOMP7ydvTljAdJYlymD7QrSzu3Ljtkm8i-jpqjjVNB3EbNkHL2LWjbClOTI2g95va1udDvUETdCGoo8P4C7y_w_ltkewQ_MJ5uH354f_TZ26tAKGvT-LgXsOFBoYa360-wLv78odPcIzs_220SSn9dNqvameVbaef0Ptmxago9NJx7QAZ6vkvujB3Eu-T2xKL6kPzoaEjrBTU0pD0a0nUa0umcdvSgjh7vKKMtCeliTpGEFEhIWxJST0LakfAROTs-Oh2fBDadRyB5ktRBlUeiymBoCFUOYnMoGS-TNGIJG4W8qnIGB-imKtWqDKuEJ0oJVimVgc4Bs3DJHpOtOTDtKaGVknmstchjJXieZZkQFRO6hOrjXObRkASulwtpY91jypVZsRnXIXnjr780UV7-euWeA62wI8H3AqNycgzkmAzJK38aAEHjWznXiwavAdUkAuUlHJInBmzf1CjHAL1RNiTpNfR7bWx8HNB3cI0mf3bjF3hO7naf3h7ZqpeNfgFydS1eWlL_BnA203U |
linkProvider | Walter de Gruyter |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NU9QwFH-jy4zAARVFq6hxxhlPZdsmTVtvyICrspzA4dbJpzAsLbPb4qx_vS_bD1bQi156aNMmeXnp-8r7PYB3IqAijBPma2aoz6gJ_VRF1JdMJDIVjCXSOfTHR3x0wr6cxqdLuTDuWKU236f1vGoQUoe6VLVzlPVYAyiBh0pNLnGBQ-dmS6LhWXU5uQ8rqUNiGcDK7qeP-9_6WAIKzEWJFUaZz3kUttCNdz_zu2i6o2-uw8aPRQi7H9-SJDp4CKqbQ3MA5WKnruSO-nkL3vH_JvkINlpFlew2nPUY7pliE1b3uvpwm_Bg3Ibln8B1h3FrZqQqiTYWb5Orm5wE4hI63aGkxj9IzgvScl85nZMuvv-BUDLHnTcjZUFc3gtB7ZSMzyeiIF0PitzkKD6Fk4P9472R3xZ08BXjvPJtFkqbInMEGq3EKFCUCY5WMqdRwKzNKF5wujYxWgSWM661pFbrFLVO_A8LugWDoizMcyBWqyw2RmaxlixDM15KS6UR-Pk4U1nogd-tZa5atHNXdGOSO6sHqZs76uaOurmjrgfv-_ZXDc7HX1tud6yRt_t9ljtcRuag_LgHb_vHuCAu_CIKU9auDSqnIaqvgQfPGpbqu4oyB9Eaph4kt3hsqY8_Dgc1XmelZy_--c03sDo6Hh_mh5-Pvr6EtQXDoXCO-DYMqmltXqHWVcnX7bb6BWjjKaM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVipwKFAKBAoYCYmTu0nsOAm3UrqUx1YcKOIW-YkqlmS1m4CWX89482hp4QKXHBIntsfjzMvzDcAzGTIZJSmnhltGObMRzXTMqOIyVZnkPFXeoT89Fkcn_O3npD9NuOyOVRr7ZdGs6hYhdWwq3XhH2YA1gBJ4rPXsGy5w5N1saTyeG3cVNjIehdkINvZfvzz8NIQSUF6uK6xwxqkQcdQhN17-yu-S6ZK6eQO2fqwj2MPwzgmiyU1Q_RTa8ydf95pa7emfF9Ad_2uOt2CrU1PJfstXt-GKLbfh2kFfHW4bNqddUP4OfO8Rbu2S1BUx1uFtMj_LSCA-ndMfSWq9g-S0JB3vVYsV6aP7LwgjK9x3S1KVxGe9ENRNyfR0JkvS96DJWYbiDpxMDj8eHNGunAPVXIiaujxSLkPWCA3aiHGoGZcCbWTB4pA7lzO84Gxdao0MneDCGMWcMRnqnPgXluwujMqqtPeBOKPzxFqVJ0bxHI14pRxTVuLnk1znUQC0X8pCd1jnvuTGrPA2DxK38MQtPHELT9wAng_t5y3Kx19b7vacUXS7fVl4VEbugfxEAE-Hx7ggPvgiS1s1vg2qphEqr2EA91qOGrqKcw_QGmUBpBdY7FwffxwO6rveRs8f_PObT2Dzw6tJ8f7N8buHcH3NbiiZY7ELo3rR2EeoctXqcbepfgHH-ShK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Strategies+to+define+performance+specifications+in+laboratory+medicine%3A+3+years+on+from+the+Milan+Strategic+Conference&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Panteghini%2C+Mauro&rft.au=Ceriotti%2C+Ferruccio&rft.au=Jones%2C+Graham&rft.au=Oosterhuis%2C+Wytze&rft.date=2017-10-26&rft.issn=1434-6621&rft.eissn=1437-4331&rft.volume=55&rft.issue=12&rft_id=info:doi/10.1515%2Fcclm-2017-0772&rft.externalDBID=n%2Fa&rft.externalDocID=10_1515_cclm_2017_0772 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon |